Article
Informing individualized multi-scale neural signatures of clozapine response in patients with treatment-refractory schizophrenia
2023-03-15
Abstract excerpt
<h4>ABSTRACT</h4> Clozapine is currently the only antipsychotic with demonstrated efficacy in treatment-refractory schizophrenia (TRS). However, response to clozapine differs widely between TRS patients, and there are no available clinical or neural predictive indicators that could be used to increase or accelerate the use of clozapine in patients who stand to benefit. Furthermore, it remains unclear how the neuro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cf31bd58-0699-5504-80a2-6669a82cd9e4
- DOI
- 10.1101/2023.03.10.23286854
